About Johnson & Johnson
Johnson & Johnson is a company based in New Brunswick (United States) founded in 1886. It operates as a Direct-to-Consumer (D2C) and Professional Services. The company has 139,800 employees as of December 31, 2024. Johnson & Johnson has completed 56 acquisitions, including 3dp.com, Abiomed and Actelion. Johnson & Johnson offers products and services including Innovative Medicine, MedTech, and Acuvue Oasys Max 1-Day Multifocal. Johnson & Johnson operates in a competitive market with competitors including GE Healthcare, Medtronic, Boston Scientific, CONMED and Commure, among others.
- Headquarter New Brunswick, United States
- Employees 139800 as on 31 Dec, 2024
- Stage Public
-
Sectors
HealthcareConsumer
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Johnson & Johnson
-
Annual Revenue
$94.19 B (USD)6.05as on Dec 31, 2025
-
Net Profit
$26.8 B (USD)90.56as on Dec 31, 2025
-
EBITDA
$28.16 B (USD)-5.01as on Dec 31, 2024
-
Latest Funding Round
$33.96 M (USD), Debt – Conventional
Feb 20, 2025
-
Investors
European Union
& 1 more
-
Employee Count
139800
as on Dec 31, 2024
-
Investments & Acquisitions
3dp.com
& 55 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Johnson & Johnson
Johnson & Johnson is a publicly listed company on the NYSE with ticker symbol JNJ in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Johnson & Johnson
Johnson & Johnson offers a comprehensive portfolio of products and services, including Innovative Medicine, MedTech, and Acuvue Oasys Max 1-Day Multifocal.
Medicines are developed for oncology and immunology needs.
Technology is created for cardiovascular and surgical solutions.
Contact lenses are designed for astigmatism with multifocal support.
People of Johnson & Johnson
Unlock access to complete
Unlock access to complete
Software Development Team
294 people
Leadership Team
141 people
Senior Team
50 people
Finance and Accounting
45 people
Data Analysis and Operations Team
41 people
Product Management Team
26 people
Legal and Compliance
26 people
Human Resources and Administration
26 people
Unlock access to complete
Funding Insights of Johnson & Johnson
Investors in Johnson & Johnson
Johnson & Johnson has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Perkins Wolf & Mc Donnell.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Johnson Johnson
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Johnson & Johnson
Johnson & Johnson has strategically engaged in corporate development activities, having acquired 56 companies. Notable acquisitions include 3dp.com, Abiomed and Actelion.
Investment portfolio details for Johnson Johnson
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
A needle-free transdermal patch for self-applicable injectables is developed.
|
Locked | Locked | 2024 | Locked | |
|
Next-generation tools for left-heart access are developed for cardiac treatments.
|
Locked | Locked | 2022 | Locked | |
|
Developer of antibody drug conjugates for the treatment of cancer
|
Locked | Locked | 2022 | Locked |
Complete acquisition details for Johnson Johnson
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Johnson Johnson
Detailed financials for Johnson Johnson
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Johnson & Johnson Comparisons
Peer comparison for Johnson Johnson
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Johnson & Johnson
Johnson & Johnson operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GE Healthcare, Medtronic, Boston Scientific, CONMED and Commure, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Materials management solutions are provided for healthcare organizations.
|
|
| Locked | Locked | Locked |
Medical equipment for treating over 30 chronic diseases is developed.
|
|
| Locked | Locked | Locked |
Wide range of medical devices
|
|
| Locked | Locked | Locked |
Surgical instruments are manufactured for multiple therapeutic areas.
|
|
| Locked | Locked | Locked |
Complex healthcare challenges are addressed through technology solutions by Commure.
|
Detailed competitors of Johnson Johnson
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Johnson & Johnson
Complete news archive for Johnson Johnson
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Johnson & Johnson
Johnson & Johnson was founded in 1886 and raised its 1st funding round 132 years after it was founded.
Johnson & Johnson is headquartered in New Brunswick, United States. It is registered at New Brunswick, New Jersey, United States.
Joaquin Duato is the current CEO of Johnson & Johnson.
As of Dec 31, 2024, the latest employee count at Johnson & Johnson is 139,800.
Annual revenue of Johnson & Johnson is $94.19B as on Dec 31, 2025.
Healthcare innovations are driven by Johnson Johnson through its focus on medicines and medical technology. Solutions are developed in areas such as oncology, immunology, neuroscience, and cardiopulmonary for its Innovative Medicine segment. The MedTech segment addresses cardiovascular, orthopaedics, surgery, and vision challenges with advanced technology. Operations are conducted across North America, EMEA, Asia Pacific, and Latin America, impacting global health equity and environmental sustainability. Social impact and caring initiatives are integrated into the companys mission to change health for humanity.
Johnson & Johnson's top competitors include GE Healthcare, Medtronic and Boston Scientific.
Johnson & Johnson offers Innovative Medicine, MedTech, and Acuvue Oasys Max 1-Day Multifocal.
Yes, Johnson & Johnson is publicly traded on NYSE under the ticker symbol JNJ.
Johnson & Johnson has 2 investors. Key investors include European Union, and Perkins Wolf & Mc Donnell.
The ticker symbol of Johnson & Johnson is JNJ on NYSE.